These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 26105457
1. PP135. Maternal serum levels of endothelial nitric oxide synthase and ADMA, an endogenous ENOS inhibitor in pregnancies complicated by severe preeclampsia. Laskowska M, Laskowska K, Oleszczuk J. Pregnancy Hypertens; 2012 Jul; 2(3):312. PubMed ID: 26105457 [Abstract] [Full Text] [Related]
2. The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction. Laskowska M, Laskowska K, Oleszczuk J. J Matern Fetal Neonatal Med; 2015 Jan; 28(1):26-32. PubMed ID: 24588201 [Abstract] [Full Text] [Related]
3. A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies. Laskowska M, Laskowska K, Terbosh M, Oleszczuk J. Med Sci Monit; 2013 Jun 05; 19():430-7. PubMed ID: 23739294 [Abstract] [Full Text] [Related]
4. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Pettersson A, Hedner T, Milsom I. Acta Obstet Gynecol Scand; 1998 Sep 05; 77(8):808-13. PubMed ID: 9776593 [Abstract] [Full Text] [Related]
5. Evaluation of sCD30 level in maternal serum in pregnancies complicated by severe preeclampsia. Laskowska M, Laskowska K, Oleszczuk J. Med Wieku Rozwoj; 2011 Sep 05; 15(1):73-8. PubMed ID: 21786515 [Abstract] [Full Text] [Related]
6. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Holden DP, Fickling SA, Whitley GS, Nussey SS. Am J Obstet Gynecol; 1998 Mar 05; 178(3):551-6. PubMed ID: 9539525 [Abstract] [Full Text] [Related]
7. Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. Kim YJ, Park HS, Lee HY, Ha EH, Suh SH, Oh SK, Yoo HS. Placenta; 2006 Mar 05; 27(4-5):438-44. PubMed ID: 16009421 [Abstract] [Full Text] [Related]
8. Interleukin-18 concentrations in pregnancies complicated by preeclampsia with and without IUGR: A comparison with normotensive pregnant women with isolated IUGR and healthy pregnant women. Laskowska M, Laskowska K, Oleszczuk J. Pregnancy Hypertens; 2011 Mar 05; 1(3-4):206-12. PubMed ID: 26009028 [Abstract] [Full Text] [Related]
9. Altered Bioavailability of Nitric Oxide and L-Arginine Is a Key Determinant of Endothelial Dysfunction in Preeclampsia. Tashie W, Fondjo LA, Owiredu WKBA, Ephraim RKD, Asare L, Adu-Gyamfi EA, Seidu L. Biomed Res Int; 2020 Mar 05; 2020():3251956. PubMed ID: 33145345 [Abstract] [Full Text] [Related]
11. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women. Laskowska M, Laskowska K, Oleszczuk J. J Matern Fetal Neonatal Med; 2012 Jun 05; 25(6):806-11. PubMed ID: 21793708 [Abstract] [Full Text] [Related]
20. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication. Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J. Med Wieku Rozwoj; 2008 Jun 05; 12(1):499-506. PubMed ID: 18663270 [Abstract] [Full Text] [Related] Page: [Next] [New Search]